Soft Tissue Sarcoma
What's New
Last Posted: Jan 19, 2023
- The Efficacy of Molecular Analysis in the Diagnosis of Bone and Soft Tissue Sarcoma: A 15-Year Mono-Institutional Study.
Benini Stefania et al. International journal of molecular sciences 2023 24(1) - Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers.
Okuma Hitomi Sumiyoshi et al. Frontiers in oncology 2021 11732525 - The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.
Gusho Charles A et al. Acta oncologica (Stockholm, Sweden) 2021 1-7 - Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
Kumamoto Tadashi et al. International journal of clinical oncology 2021 - Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study.
Liu Shunli et al. European radiology 2021 - Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
Shern Jack F et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 JCO2003060 - Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.
Kim Jung et al. JCO precision oncology 2021 5 - Development of machine learning model algorithm for prediction of 5-year soft tissue myxoid liposarcoma survival.
Kamalapathy Pramod N et al. Journal of surgical oncology 2021 - Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.
Perreault Sébastien et al. Current oncology (Toronto, Ont.) 2021 Jan 28(1) 346-366 - A Prognostic Molecular Signature of N⁶-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
Hou Mingming et al. Medical science monitor : international medical journal of experimental and clinical research 2020 Dec 26e928400
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: